A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal Hypertension

Learn more about:
Related Clinical Trial
Multimodal Ultrasound and Portal Hypertension Portal Vein Access During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedures Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension. CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302) EUS-PPG vs HVPG in Portal Hypertension Hepatic Venous Pressure Gradient and Elastography in Porto-sinusoidal Vascular Disorder Portal Hypertension Using Magnetic Resonance Elastography Carvedilol vs. Propranolol in Second Prophylaxis of Variceal Bleeding Portal Hypetension and Bariatric Surgery (BARIAPORTAL) Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics Technology Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices Relevance of Sarcopenia in Advanced Liver Disease The Instant Efficacy and Safety of Alverine in Decreasing Portal Hypertension: an Exploratory Pilot Study Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial 3D-MRE for Assessing Cirrhosis and Portal Hypertension Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal Hepatectomy for Early-stage HCC Patients With CSPH An AI Model Based on Smartphone-derived Multimodality Images to Evaluate Portal Hypertension in Patients With Cirrhosis (CHESS2203) The Use of Endoscopic Ultrasound-Guided Portal Pressure Measurements to Guide Beta-Blocker Therapy in Patients With Compensated Cirrhosis The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients A Combined Model Based on Spleen Stiffness, Liver Stiffness and Platelets for Assessing Portal Hypertension in Compensated Cirrhosis. Vonoprazan Efficacy to Prevent Post Variceal Band Ligation Ulcer EUS vs TJ for Liver Biopsy and Portal Pressure Gradient Measurement Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease A Novel Imging Based Quantitative Model-aided Detection of Portal Hypertension in Patients With Cirrhosis A Novel Spleen-dedicated Stiffness Measured by FibroScan to Evaluate Cirrhotic Portal Hypertension (CHESS2105) Myocardial Fibrosis and Inflammation in Liver Cirrhosis Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant Extension Study of Carvedilol RCT Study Endoscopic Resection of Early Esophageal Tumors in the Context of Cirrhosis or Portal Hypertension Characterization and Pathogenesis of ACLF Timing of Endoscopy for Acute Variceal Bleeding in Patients With Cirrhosis The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D) Efficacy and Safety of EUS-guided Coil Combined With Endoscopic Cyanoacrylate Injection Versus BRTO in Patients With Spontaneous Portosystemic Shunt The Effect of Monitoring PVP on Clinical Outcomes in Patients With PH Effect of Antiviral Therapy on HVPG in Patients With Viral Cirrhosis Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension The vPPG-detecting Software Guided Management of Cirrhotic Portal Hypertension Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal Hypertension TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites EUS Guided Portal-systemic Pressure Gradient Measurement Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005) Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease Liver Incytes for Portal Hypertension Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14 Portal Pressure Effects of Phlebotomy Combined to Vasopressin Use in Cirrhotic Patients Undergoing Liver Transplantation The Precise Selection of Stent Diameter for Portal Hypertension Patients With TIPS A Physical Activity Program in End-state Liver Disease MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI) Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS Ivabradine in Cirrhotic Cardiomyopathy Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices TIPS With 8- OR 10-mm Covered Stent for Preventing Variceal Rebleeding A Trial of Somatostatin With Endoscopic Variceal Ligation (EVL) in Control of Acute Variceal Bleeding Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis Effects of a Novel Physical Exercise Program in Patients With Cirrhosis (the LFN-exercise Protocol) MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis Short Course Terlipressin for Control of Acute Variceal Bleeding Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis Role of SWE-change After TIPS in the Prediction of Prognosis After TIPS Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction Injection of Cyanoacrylate+Lipiodol vs Cyanoacrylate+Lauromacrogol in Gastric Varices Comparing Two Methods to Stop Vomiting of Blood Using the Endoscope Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis A Prospective Evaluation of Computerized Tomographic(CT) Scanning as a Screening Modality for Esophageal Varices Secondary Prophylaxis After Variceal Bleeding in Non-Responders VICIS – Vienna Cirrhosis Study The Influence of Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy Impact of Transjugular Intrahepatic Portosystemic Shunts on Liver Stiffness Quality of Life and Nutritional Improvements in Cirrhotic Patients Treatment for Prevention of Variceal Rebleeding Guided by the Hemodynamic Response 8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding in Patients With Child A Cirrhosis 3D CT Guidance for Transjugular Intrahepatic Portosystemic Shunt Creation 8mm-TIPS Versus Endoscopic Variceal Ligation (EVL) Plus Propranolol for Prevention of Variceal Rebleeding Evaluation of 3D Overlay During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure RCT of Carvedilol Versus Variceal Band Ligation in the Primary Prophylaxis of Oesophageal Variceal Haemorrhage Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey Surrogate Markers of Portal Pressure Effects of Dark vs. White Chocolate on the Postprandial Increase in Portal Pressure in Cirrhosis A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis DS-MCE vs EGD for Diagnosing Gastroesophageal Varices Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis Transfusion Requirements in Gastrointestinal (GI) Bleeding FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE) Austrian Registry on Transjugular Intrahepatic Portosystemic Shunts Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding Somatostatin in Living Donor Liver Transplantation The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP). Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE 3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic Shunts Endoscopic Variceal Ligation (EVL)+ Drugs Versus Endoscopic Variceal Ligation (EVL) Alone For Secondary Prophylaxis Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment The Role of Somatostatin in the Hemodynamics of the Hepatic Circulation in Patients Undergoing Liver Resection TIPS in Fundal Variceal Bleeding (the TFB Study) Prevention of Esophageal Varices by Beta-Adrenergic Blockers Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis Vasoactive Peptides in Portal Pressure Correlation of Platelets Count With Endoscopic Findings in a Cohort of Egyptian Patients With Liver Cirrhosis Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients Non-invasive Evaluation Program for TIPS and Follow Up Network A Novel Approach for Transjugular Intrahepatic Portocaval Shunt Creation Using Real-time Three Dimensional Roadmap Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After Simvastatin Feasibility And Safety Of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation Using A Radiofrequency Guidewire A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive Cirrhotic Patients Anticoagulation Therapy After Splenectomy in Cirrhosis Patient Carvedilol for Prevention of Esophageal Varices Progression Esophageal Capsule Endoscopy in Children Splenic Embolization for Portal Hypertension Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis HVPG for Rebleeding Risk Stratification Non-invasive Evaluation Program for TIPS and Follow Up Network 2 (NEPTUN2) Early TIPS for Ascites Study Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPS Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension Can MRI Evaluate Beta-blocker Response in Portal Hypertension? Effect of Administration of Rifaximin on the Portal Pressure of Patients With Liver Cirrhosis and Esophageal Varices Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C) Danish Carvedilol Study in Portal Hypertension Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension The Effect of Probiotics (VSL) on Portal Hypertension Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI) Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients HVPG-guided Laparoscopic Versus Endoscopic Therapy for Variceal Rebleeding in Portal Hypertension: A Multicenter Randomized Controlled Trial (CHESS1803) Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension Evaluation of Probiotics in the Treatment of Portal Hypertension Simvastatin Effect on Portal Hypertension A Study to Investigate the Safety and Effect of the Study Drug (FE 204205) in Patients With Cirrhotic Portal Hypertension Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension Viatorr CX Case-control Study for Complications of Portal Hypertension Risk Factors for Variceal Bleeding in Egyptian Patients With Non-Cirrhotic Portal Hypertension Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal Hypertension Value of Von Willebrand Factor in Portal Hypertension Assessment of Portal Hypertension With Multiparametric MRI Portal Hypertension and Systemic Endothelial Function Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension Probiotics for Liver Cirrhosis With Portal Hypertension WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver Cirrhosis Hemodynamic Effect of Simvastatin With Beta Blockers in Clinical Portal Hypertension Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and Entecavir Assessing Outcome After H-graft Shunt Placement Microparticles in Cirrhosis and Portal Hypertension ABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver Cirrhosis MRI in Portal Hypertension Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients. Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir

Recruitment Information


Administrative Informations